Discover
MRK
Merck & Co., Inc.
126.26
1 x 126.26
1 x 126.94
bid
ask
+
0.00
0.00%
200 @ 09:23 AM
126.80 +0.54 (0.43%)
| Ytd | 19.95% | |
| 1y | 59.20% |
day range
76.66
52 week range
131.74
| Open | Prev Close | 126.26 | Low | High | Mkt Cap | 311.86B | |||
| Vol | 0.00 | Avg Vol | 10.32M | EPS | 5.47 | P/E | 23.08 | Forward P/E | 24.51 |
| Beta | 0.19 | Short Ratio | 2.48 | Inst. Own | 82.20% | Dividend | 3.40 | Div Yield | 2.67 |
| Ex Div Date | 06-15 | Earning | 08-04 | 50-d Avg | 119.74 | 200-d Avg | 109.70 | 1yr Est | 132.78 |
| Income Statement | |||
| Total Revenue | 16.29B | ||
| Revenues (USD) | 16.29B | ||
| Cost of Revenue | 4.20B | ||
| Gross Profit | 12.09B | ||
| Operating Expenses | 15.49B | ||
| Research and Development Expense | 12.59B | ||
| Selling, General and Administrative Expense | 2.70B | ||
| Operating Income | -3.40B | ||
| Interest Expense | 479.00M | ||
| Income Tax Expense | 709.00M | ||
| Net Income | -4.24B | ||
| Net Income Common Stock | -4.24B | ||
| Net Income Common Stock (USD) | -4.24B | ||
| Consolidated Income | -4.24B | ||
| Net Income to Non-Controlling Interests | -3.00M | ||
| Earnings per Basic Share | -1.72 | ||
| Earnings per Basic Share (USD) | -1.72 | ||
| Earnings per Diluted Share | -1.72 | ||
| Dividends per Basic Common Share | 0.85 | ||
| Earning Before Interest & Taxes (EBIT) | -3.05B | ||
| Earning Before Interest & Taxes (USD) | -3.05B | ||
| Weighted Average Shares | 2.47B | ||
| Weighted Average Shares Diluted | 2.47B | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.33B | ||
| Cash and Equivalents (USD) | 5.33B | ||
| Investments | 1.48B | ||
| Investments Current | 375.00M | ||
| Investments Non-Current | 1.11B | ||
| Trade and Non-Trade Receivables | 12.21B | ||
| Current Assets | 35.02B | ||
| Property, Plant & Equipment Net | 25.43B | ||
| Total Assets | 128.69B | ||
| Debt Current | 2.44B | ||
| Total Debt | 49.12B | ||
| Current Liabilities | 26.95B | ||
| Debt Non-Current | 46.67B | ||
| Total Liabilities | 82.75B | ||
| Accumulated Retained Earnings (Deficit) | 66.72B | ||
| Accumulated Other Comprehensive Income | -4.06B | ||
| Shareholders Equity | 45.88B | ||
| Shareholders Equity (USD) | 45.88B | ||
| Assets Non-Current | 93.67B | ||
| Total Debt (USD) | 49.12B | ||
| Goodwill and Intangible Assets | 47.33B | ||
| Inventory | 6.48B | ||
| Liabilities Non-Current | 55.81B | ||
| Trade and Non-Trade Payables | 3.86B | ||
| Tax Liabilities | 5.44B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.51B | ||
| Net Cash Flow from Financing | -2.98B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.29B | ||
| Capital Expenditure | -991.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -8.78B | ||
| Issuance (Purchase) of Equity Shares | -717.00M | ||
| Issuance (Repayment) of Debt Securities | -79.00M | ||
| Payment of Dividends & Other Cash Distributions | -2.10B | ||
| Net Cash Flow from Investing | -10.21B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -374.00M | ||
| Net Cash Flow from Operations | 3.92B | ||
| Effect of Exchange Rate Changes on Cash | -19.00M | ||
| Share Based Compensation | 185.00M | ||